Search | BIO

Home

Search

408 Results Found

Market Outlook—Leveraging Market Corrections for M&A or IPOs

After a multi-year expansion of company formation and in biopharma valuations, 2018 was a year of heightened market volatility. Investors’ eagerness to support new modalities enabled more than 50 biotech IPOs, but with much less mature clinical development progress than traditionally demonstrated…

Meet Kallyope’s Nancy Thornberry, Fireside Chat Speaker at #BIOCEO19

Biotech startups come in all shapes, sizes and approaches but have one thing in common: the drive to develop technology that will address a high unmet need and improve patients’ lives. Nancy Thornberry, the current CEO of Kallyope Inc., didn’t always work for startups, but she has spent a…

Using Decision Science for Negotiations: Getting to Win-Win

New medicines often progress from idea to regulatory approval through collaborative licensing agreements or acquisition. Deal-making has become one of the most critical skills for a biotech’s leadership team in developing products to improve patients’ lives. On February 10 BIO will…

Researcher looking at substance underneath a microscope

Meet Opiant’s Roger Crystal, Fireside Chat Speaker at #BIOCEO19

When pop star Demi Lovato experienced an apparent opioid-related overdose last summer, reports stated that she was saved by a medication called NARCAN® Nasal Spray — the first FDA-approved nasal form of naloxone, an opioid antagonist. The company that developed NARCAN® Nasal Spray is Opiant…

It Starts with One—Partnering Meeting Leads to Unique Public-Private Partnership

Roy Zwahlen took a long shot when he requested a meeting with an investment firm at the 2017 BIO International Convention in San Diego. As Assistant Dean for Innovation and Strategy at the UNC Eshelman School of Pharmacy and the Eshelman Institute for Innovation, Zwahlen was in search of a…

It Starts with One—Presentation at BIO 2018 Leads to International Agreement

A recently announced agreement between the New Jersey Economic Development Authority and the Israel Innovation Authority is a fitting testament to the theme for the upcoming BIO 2019 International Convention: It Starts with One. In the intensely innovative biotechnology space, one meeting; one…

Opportunities for Patient and Health Advocates

Last week, the seventh annual Patient and Health Advocacy Summit brought hundreds of patient advocates, industry experts and policymakers together to engage on important issues facing the patient community. The summit concluded with a session on patient-focused drug development (PFDD) with…

Investment Market Good for Deal-making at #BIF18

As we move into the final quarter of 2018, we reflect on a year with a strong IPO market that has created a hefty appetite for alliances, a bevy of notable M&A deals, a corporate tax reform package that has encouraged deal-making, and a biotech patent cliff that is driving even more companies…

National Immunization Awareness Month is Timely Reminder of Modern Marvel of Vaccines

August marks National Immunization Awareness Month – a time to take inventory on where we stand, and recognize how far we’ve come, in advancing breakthrough vaccines designed to protect the world’s population. However, despite the clear societal and economic benefits that come with common…

#MakeHistory: Highlighting History I China

Venture capital investment in US biotech companies has skyrocketed as Chinese investors continue to fuel the US pharmaceutical startup sector. With over $1.4 billion invested by Chinese VC funds into private US biotechnology firms in Q1 2018 alone, the Chinese investment community represents a…